Welcome to our dedicated page for UpHealth news (Ticker: UPH), a resource for investors and traders seeking the latest updates and insights on UpHealth stock.
UpHealth, Inc. (UPH) delivers integrated digital health solutions through telehealth platforms and evidence-based treatment programs. This news hub provides investors and stakeholders with official updates on corporate developments, clinical initiatives, and strategic partnerships.
Access timely press releases, earnings reports, and operational updates covering UpHealth's behavioral health services, including mental health programs, substance use disorder treatments, and digital care coordination advancements. Our curated collection features announcements about service expansions, technology implementations, and healthcare provider collaborations.
This resource enables efficient tracking of UpHealth's progress in merging clinical expertise with digital innovation. Users can monitor updates about care delivery models, regulatory compliance milestones, and health system partnerships. Bookmark this page for direct access to verified information about UPH's position in the evolving digital healthcare market.
UpHealth, Inc. announced the delay of its Annual Meeting due to a ruling from the Delaware Court of Chancery, which will review evidence from a lawsuit aimed at altering the company's quorum requirements. Current directors will remain in office, and shareholders are advised to take no immediate action. The court has expressed confidence in the defendants' good faith, while UpHealth is committed to protecting shareholder interests and addressing the actions of the 'Conflicted Group.' Over 75% of shares not owned by this group submitted proxies ahead of the meeting.
UpHealth, Inc. (NYSE: UPH) announced a significant change in its Board of Directors, appointing Dr. Avi Katz as the Sole Independent Chairman after removing Dr. Chirinjeev Kathuria from the Co-Chairman role due to ongoing litigation initiated by Dr. Kathuria against the Company and several independent directors. This decision aims to prevent potential deadlock and ensure effective Board operations at a critical juncture for the Company. UpHealth remains focused on enhancing global healthcare access and quality, with a stockholder meeting scheduled for June 28, 2022.
UpHealth, Inc. (NYSE: UPH) stockholders are advised by the UpHealth Concerned Stockholders to wait for the BLUE proxy card for the upcoming 2022 Annual Meeting, scheduled for June 28. They urge stockholders to avoid using the white proxy card from the Company, which they believe would not serve their best interests. The Concerned Stockholders plan to solicit votes to replace existing directors with three independent nominees to enhance stockholder value. They emphasize the need for new expertise on the Board.
On June 1, 2022, UpHealth (NYSE: UPH) announced the election of Erika Shell Castro as president of the National Council on Interpreting in Health Care (NCIHC) Board of Directors. NCIHC aims to enhance language access in U.S. healthcare. Previously the Vice President and Chair of the Membership and Outreach Committee at NCIHC, Shell Castro has received accolades for her contributions to linguistic competence in healthcare. She will leverage her experience to promote equitable healthcare access for diverse populations, aligning with UpHealth’s mission of improving healthcare delivery.
UpHealth, Inc. (NYSE: UPH) announces the appointment of Daniel Mandoli as Executive Vice President of U.S. Services, effective June 13, 2022. Mandoli brings extensive experience, having previously increased revenues over tenfold at Cordant Health Solutions. He also held senior roles at Express Scripts, managing a $19 billion business. His leadership is expected to accelerate growth in UpHealth's U.S. Services Division, which includes Medquest Digital Pharmacy and UpHealth Behavioral Health.
UpHealth, Inc. (NYSE: UPH) announced its participation in two virtual investor conferences. The events are the Benchmark Company Healthcare House Call Virtual Video Conference on June 2, 2022, and the NYSE Healthcare & Technology Virtual Investor Access Day on June 8, 2022. CEO Dr. Ramesh Balakrishnan and CFO Martin Beck will attend these conferences, available for one-on-one and small group meetings. UpHealth focuses on digital health solutions, enhancing care delivery and management, aiming to improve access, affordability, quality, outcomes, and patient experience.
UpHealth, Inc. (NYSE: UPH) announced that its interpretation service, Martti™, has successfully provided over 1.5 million minutes of translation at a leading New Jersey healthcare system. Since its integration in October 2021, Martti™ has facilitated communication for over 118,000 patients, supporting health equity and effective care. With nearly 1,200 devices deployed, the service boasts a provider satisfaction rating of 4.8 out of 5 stars. Martti™ connects patients to qualified interpreters in over 250 languages, enhancing access to healthcare for diverse populations.
UpHealth, Inc. (NYSE: UPH) announced a significant achievement with its telehealth platform, Martti™, which recorded a 53% growth in Q1 and generated an estimated $8 million in new contract value over three years. Martti™ enhances healthcare access through language interpretation across more than 2,300 venues in the U.S., serving over 575,423 patients in Q1 alone. The platform has also secured two major contracts with Ascension and Wellstar, emphasizing its commitment to innovate healthcare delivery and improve patient experiences.
UpHealth, Inc. (NYSE: UPH) announced Q1 2022 revenue of $36.0 million, a 6% sequential increase and 18% growth year-over-year. Gross margin improved to 43% from 22% in Q4 2021. The company confirmed its 2022 revenue outlook between $205 and $233 million, projecting a 38-56% growth rate. CEO Dr. Ramesh Balakrishnan praised the company's progress in health technology, noting the focus on high-growth segments. Samuel J. Meckey will succeed Balakrishnan as CEO in July, bringing extensive healthcare experience.
UpHealth, Inc. (NYSE: UPH) announces the appointment of Samuel J. Meckey as CEO, effective July. Meckey brings extensive healthcare experience, previously serving as EVP at EXLService, where he significantly improved revenue and operations. His leadership is expected to enhance UpHealth's growth potential in the healthcare sector. He succeeds Dr. Ramesh Balakrishnan, who will take on the role of Chief Strategy Officer. The Board expressed confidence in Meckey's ability to drive transformation and operational excellence at UpHealth.
